Fertility Control
-
SenesTech Announces Closing of $6.3 Million Warrant Exercise
SenesTech, Inc. (SNES), a biotech company specializing in fertility control for pest management, announced the closing of a warrant exercise generating $6.3 million. The company issued new short-term warrants priced at $0.125, potentially yielding an additional $11.5 million if fully exercised. SenesTech intends to use the net proceeds for working capital and general corporate initiatives. Their flagship product, ContraPest®, is a registered contraceptive for rats, aiming for humane and ecologically-sound pest control.
